Zobrazeno 1 - 10
of 162
pro vyhledávání: '"398"'
Autor:
Anna Wijatyk, Dhan Chand, Remigiusz Kaleta, Steven J. O'Day, Lernik Ohanjanian Namagerdi, Michael S. Gordon, Serina, Anthony El khoueiry, Olivia Wijatyk, Haiyong Han, Jennifer Buell, Marek Ancukiewicz, Chethan Ramamurthy, Waldo Ortuzar, Irina M. Shapiro, Andrea J. Bullock
Publikováno v:
Regular and young investigator award abstracts.
Background Immune checkpoint therapies targeting CTLA-4, alone, or in combination with anti-PD-1 have shown durable responses in cancer patients. However, responses are limited to a small subset of patients in the most common immunogenic cancers. Her
Autor:
Nanae Tsuruoka, Ryuichi Iwakiri, Megumi Hara, Yasuhisa Sakata, Shinichi Ogata, Yoichiro Ito, Kazuma Fujimoto, Naoyuki Tominaga, Koji Yamamoto, Ryo Shimoda, Atsushi Nakayama
Publikováno v:
Internal Medicine
Objective The aim of this study was to clarify the safety of colorectal endoscopic submucosal dissection (ESD) during the era of health insurance coverage starting from April 2012 in Japan. Methods Between April 2012 and May 2016, ESD was applied to
Publikováno v:
Cancer Research. 81:398-398
Purpose: Tumor mutational burden (TMB) is emerging as a promising biomarker in immune checkpoint inhibitor therapy. Although whole-exome sequencing (WES) is the gold standard to quantify TMB, most TMB measurements in routine diagnostic applications w
Autor:
Alison Conlin, William L. Redmond, Staci Mellinger, Sasha E. Stanton, Nicole Moxon, Yaping Wu, Janet Ruzich, Parvin Peddi, David L. Page, Zhaoyu Sun, Katherine Sanchez, Kelly Shea Perlewitz
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A430-A430
BackgroundBackground: The FDA has approved pembrolizumab in combination with neoadjuvant chemotherapy (doxorubicin, cyclophosphamide, paclitaxel [ACT], and carboplatin) for stage II/III TNBC, on the basis of improved event free survival (EFS) and pat
Publikováno v:
Journal of Urology. 185
INTRODUCTION AND OBJECTIVES: Rictor is a key member of mTORC2, which is crucial to various carcinoma. We measured Rictor expression levels in tumor tissues and six RCC cell lines and evaluated its significance and prognostic use in renal cell carcino
Autor:
Kyu Rokkaku, Keiichi Kubota, T. Sawada, Mitsugi Shimoda, Junji Kita, Mitsuru Ishizuka, M. Kato
Publikováno v:
Journal of Clinical Oncology. 28:4111-4111
4111 Background: Few studies have investigated the Glasgow Prognostic Score (GPS) in patients with hepatocellular carcinoma (HCC). Methods: To compare the prognostic value of the GPS and Cancer of ...
Autor:
Manolis Tsiknakis, Georgios S. Stamatakos, Norbert Graf, Christine Desmedt, A. Hoppe, Dimitra D. Dionysiou
Publikováno v:
European Journal of Cancer Supplements. 5:83
Autor:
Yuichiro Imai, Kumiko Aoki, Mao Kawakami, Tadaaki Kirita, Nobuhiro Ueda, Hiroko Shimotsuji, Chie Nakashima
Publikováno v:
Journal of Bone and Mineral Metabolism. 39:623-630
Bone-modifying agents (BMAs) are indispensable to cancer therapy. However, the number of patients with medication-related osteonecrosis of the jaw (MRONJ) is increasing according to the BMA administration. Oral factors predisposing to development of
Autor:
Jeong-Won Lee, Won Kyung Cho, Byoung-Gie Kim, Joseph J Noh, Chel Hun Choi, Jung In Shim, Hie Jun Yeo, Soo Young Jeong, Tae-Joong Kim, Yoo-Young Lee, Duk-Soo Bae, Jun-Hyeok Kang, Won Soon Park
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3471, p 3471 (2020)
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3471, p 3471 (2020)
Volume 9
Issue 11
This study aimed to evaluate the prognostic significance of tumor regression rate according to radiation phase and histologic subtype in patients with locally advanced cervical cancer (LACC) treated with chemoradiation. We retrospectively reviewed th
Autor:
Jin Gu Kang, Seung In Seo, Won Hyuk Choi, Jun Ho Park, Hak Yang Kim, Woon Geon Shin, Min Jeong Kim
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 5
Journal of Clinical Medicine, Vol 9, Iss 1275, p 1275 (2020)
Volume 9
Issue 5
Journal of Clinical Medicine, Vol 9, Iss 1275, p 1275 (2020)
(Background) The aim of this study was to investigate the prognostic impact of lymphatic invasion in gastric cancer, focusing on survival differences between N stage groups. (Methods) A total of 398 consecutive patients who underwent curative gastrec